Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluation of Deviation From Planned Cohort Size and Operating Characteristics of Phase 1 Trials

JAMA Network Open(2021)10.1001/jamanetworkopen.2020.37563Source: DataRank Database

Evaluation of Deviation From Planned Cohort Size and Operating Characteristics of Phase 1 Trials is a research paper published in JAMA Network Open (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (27)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Suyu Liu ORCID,Timothy A. Yap ORCID,Ying Yuan ORCID,Minjeong Park ORCID

Live enrichment

PubMed:33595664 PMC:PMC7890531

NCI NIH HHS

Grant: P50 CA127001

NCI NIH HHS

Grant: P50 CA221707

National Institutes of Health

Grant: 3P50CA127001-10S1

SPORE in Brain Cancer

National Institutes of Health

Grant: 3P50CA098258-15S1

MD Anderson Gynecologic SPORE for Uterine Cancers

National Institutes of Health

Grant: 5P50CA221707-03

MD Anderson Cancer Center SPORE in Gastrointestinal Cancer

goldLicense: cc-by

publisherhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2776531/park_2021_oi_201128_1612905992.18152.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7890531

Europe_PMChttps://europepmc.org/articles/PMC7890531

https://doi.org/10.1001/jamanetworkopen.2020.37563

https://pubmed.ncbi.nlm.nih.gov/33595664

Fields of Study

01 natural sciences03 medical and health sciences0302 clinical medicine0101 mathematics

MeSH Terms

HumansNeoplasmsAntineoplastic AgentsBayes TheoremCross-Sectional StudiesSample SizeMaximum Tolerated DoseResearch DesignComputer SimulationClinical Trials, Phase I as TopicClinical Trial Protocols as Topic

Keywords

Clinical Trials, Phase I as TopicMaximum Tolerated DoseAntineoplastic AgentsBayes TheoremClinical Trial Protocols as TopicCross-Sectional StudiesResearch DesignNeoplasmsSample SizeHumansComputer SimulationOriginal Investigation

Sustainable Development Goals

SDG 3: 3. Good health